Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (5)

2023

  1. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

2022

  1. Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 12

  2. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

2013

  1. Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 103-109

2011

  1. Impacto de los nuevos criterios para el tratamiento anticoagulante de la fibrilación auricular

    Revista Espanola de Cardiologia, Vol. 64, Núm. 8, pp. 649-653